Skip to Main Content

Paper Details

Prostate cancer reactivates developmental epigenomic programs during metastatic progression.
Nat Genet
140
2020
AR, AR sites, FOXA1, HOXB13, NKX3-1, PCa, PCa cells, Prostate cancer, Reprogrammed regulatory elements, androgen, androgen receptor, epigenomic, human, metastases, metastasis-specific enhancers, metastatic PCa, metastatic disease, prostate cancer, prostate lineage-specific regulatory elements, reactivated regulatory elements, reprogrammed AR sites, tumor
Author NameAffiliation
Mark M PomerantzDana-Farber Cancer Institute, Harvard Medical School
Mark M PomerantzDana-Farber Cancer Institute, Harvard Medical School
Yanyun ZhuOncode Institute, The Netherlands Cancer Institute
David Y TakedaDana-Farber Cancer Institute, Harvard Medical School
David Y TakedaThe Eli and Edythe L. Broad Institute
Sylvan C BacaDana-Farber Cancer Institute, Harvard Medical School
Alexander GusevDana-Farber Cancer Institute, Harvard Medical School
Alexander GusevDana-Farber Cancer Institute, Harvard Medical School
Tesa M SeversonOncode Institute, The Netherlands Cancer Institute
Bogdan PasaniucDavid Geffen School of Medicine, University of California los angeles
Bogdan PasaniucDavid Geffen School of Medicine, University of California los angeles
Bogdan PasaniucDavid Geffen School of Medicine, University of California los angeles
Bogdan PasaniucDavid Geffen School of Medicine, University of California los angeles
Connor BellDana-Farber Cancer Institute, Harvard Medical School
Edward O'ConnorDana-Farber Cancer Institute, Harvard Medical School
Rosina T LisDana-Farber Cancer Institute, Harvard Medical School
Lewyn LiDana-Farber Cancer Institute, Harvard Medical School
Andries M BergmanOncode Institute, The Netherlands Cancer Institute
Andries M BergmanThe Netherlands Cancer Institute
Andries M BergmanThe Netherlands Cancer Institute
Simon A GaytherCenter for Bioinformatics and Functional Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Rosario I CoronaCenter for Bioinformatics and Functional Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Rosario I CoronaSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Toni K ChoueiriDana-Farber Cancer Institute, Harvard Medical School
Leigh EllisDana-Farber Cancer Institute
Isla P GarrawayDavid Geffen School of Medicine, University of California los angeles
Isla P GarrawayGreater Los Angeles VA Healthcare System
Eva CoreyUniversity of Washington
Wilbert ZwartOncode Institute, The Netherlands Cancer Institute
Wilbert ZwartLaboratory of Chemical Biology and Institute for Complex Molecular Systems, Eindhoven University of Technology
Matthew L FreedmanDana-Farber Cancer Institute, Harvard Medical School
Matthew L FreedmanThe Eli and Edythe L. Broad Institute
Matthew L FreedmanDana-Farber Cancer Institute, Harvard Medical School
Matthew L FreedmanThe Eli and Edythe L. Broad Institute
  • 1 - 34

Datasets